These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30450095)

  • 1. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
    Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
    Front Immunol; 2018; 9():2488. PubMed ID: 30450095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sm29, but not Sm22.6 retains its ability to induce a protective immune response in mice previously exposed to a Schistosoma mansoni infection.
    Alves CC; Araujo N; dos Santos VC; Couto FB; Assis NR; Morais SB; Oliveira SC; Fonseca CT
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003537. PubMed ID: 25723525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
    Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
    Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective immune response induced in mice by immunization with Schistosoma mansoni schistosomula tegument (Smteg) in association with CpG-ODN.
    Teixeira de Melo T; Araujo JM; Campos de Sena I; Carvalho Alves C; Araujo N; Toscano Fonseca C
    Microbes Infect; 2013 Jan; 15(1):28-36. PubMed ID: 23099420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies.
    Cardoso FC; Pacífico RN; Mortara RA; Oliveira SC
    Clin Exp Immunol; 2006 Jun; 144(3):382-91. PubMed ID: 16734606
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
    J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of mice with a 30 kDa Schistosoma antigen with and without human adjuvant induces high protection against S. mansoni infection.
    Attallah AM; Abdel Aziz MM; Abbas AT; Elbakry KA; El-Sharabasy MM
    J Helminthol; 2004 Sep; 78(3):189-94. PubMed ID: 15469619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies are involved in the protective immunity induced in mice by Schistosoma mansoni schistosomula tegument (Smteg) immunization.
    Melo TT; Sena IC; Araujo N; Fonseca CT
    Parasite Immunol; 2014 Feb; 36(2):107-11. PubMed ID: 24558655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection.
    Da'Dara AA; Skelly PJ; Walker CM; Harn DA
    Parasite Immunol; 2003; 25(8-9):429-37. PubMed ID: 14651590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schistosoma mansoni antigen Sm-p80: Prophylactic efficacy of a vaccine formulated in human approved plasmid vector and adjuvant (VR 1020 and alum).
    Zhang W; Ahmad G; Torben W; Siddiqui AA
    Acta Trop; 2011 May; 118(2):142-51. PubMed ID: 21334302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
    de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
    Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of a protective immunity against Schistosoma mansoni with ovalbumin-coupled Sm37-5 coadsorbed with granulocyte-macrophage colony stimulating factor (GM-CSF) or IL-12 on alum.
    Argiro L; Henri S; Dessein H; Dessein AJ; Bourgois A
    Vaccine; 1999 Jan; 17(1):13-8. PubMed ID: 10078602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity, antibody responses and vaccine efficacy of recombinant annexin B30 against Schistosoma mansoni.
    Leow CY; Willis C; Chuah C; Leow CH; Jones M
    Parasite Immunol; 2020 Mar; 42(3):e12693. PubMed ID: 31880816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sm16, A
    Bernardes WPOS; de Araújo JM; Carvalho GB; Alves CC; de Moura Coelho AT; Dutra ITS; Teixeira SSF; de Azambuja Ribeiro RIM; de Moraes Mourão M; da Silva-Pereira RA; Fonseca CT
    J Immunol Res; 2019; 2019():6793596. PubMed ID: 31886307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.